Bayer clears EU hurdle for $62.5-bn takeover of Monsanto with BASF sale

The tie-up is set to create a company with control of more than a quarter of the world's seed and pesticides market

Logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany
Logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany
Reuters BRUSSELS
Last Updated : Mar 21 2018 | 6:21 PM IST

German conglomerate Bayer won EU antitrust approval on Wednesday for it's $62.5 billion buys of US peer Monsanto, the last of a trio of mega-mergers that will reshape the agrochemicals industry.

The tie-up is set to create a company with control of more than a quarter of the world's seed and pesticides market.

Driven by shifting weather patterns, competition in grain exports and a faltering global farm economy, Dow and Dupont, and ChemChina and Syngenta had earlier led the wave of consolidation in the sector.

Environmental and farming groups have opposed all three deals, worried about their power and their advantage in digital farming data, which can tell farmers how and when to till, sow, spray, fertilise and pick crops based on algorithms.

The European Commission said Bayer addressed its concerns with its offer to sell a swathe of assets to boost rival BASF confirming a Reuters story on February 28.

"Our decision ensures that there will be effective competition and innovation in seeds, pesticides and digital agriculture markets also after this merger," European Competition Commissioner Margrethe Vestager said in a statement.

"In particular, we have made sure that the number of global players actively competing in these markets stays the same."

Bayer has already reached a deal to sell certain seed and herbicide assets for 5.9 billion euros ($7.2 billion) to BASF and to give it a license to its global digital farming data. It will also divest its vegetable seeds business to BASF.

The Commission is due to decide on the BASF deal by April 16.

China has given conditional approval to the Bayer and Monsanto deal, which has won the green light in Brazil. It is currently being reviewed by US and Russia antitrust authorities.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 21 2018 | 6:20 PM IST

Next Story